tiprankstipranks
Trending News
More News >
Takara Bio Inc. (JP:4974)
:4974
Japanese Market
Advertisement

Takara Bio Inc. (4974) Financial Statements

Compare
2 Followers

Takara Bio Inc. Financial Overview

Takara Bio Inc.'s market cap is currently ¥98.50B. The company's EPS TTM is ¥20.1; its P/E ratio is 94.62; and it has a dividend yield of 2.08%. Takara Bio Inc. is scheduled to report earnings on May 13, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue¥ 45.04B¥ 43.51B¥ 78.14B¥ 67.70B¥ 46.09B
Gross Profit¥ 26.07B¥ 26.91B¥ 44.77B¥ 49.21B¥ 31.87B
Operating Income¥ 2.26B¥ 3.00B¥ 20.54B¥ 28.90B¥ 13.95B
EBITDA¥ 6.50B¥ 7.90B¥ 25.28B¥ 33.05B¥ 17.74B
Net Income¥ 1.04B¥ 1.48B¥ 16.01B¥ 19.85B¥ 9.55B
Balance Sheet
Cash & Short-Term Investments¥ 29.55B¥ 35.42B¥ 51.85B¥ 23.63B¥ 25.99B
Total Assets¥ 125.33B¥ 123.21B¥ 129.20B¥ 115.71B¥ 90.98B
Total Debt¥ 1.10B¥ 968.00M¥ 972.00M¥ 1.05B¥ 1.14B
Net Debt¥ -28.45B¥ -32.20B¥ -48.09B¥ -21.11B¥ -22.17B
Total Liabilities¥ 9.48B¥ 11.42B¥ 16.75B¥ 19.65B¥ 16.68B
Stockholders' Equity¥ 115.50B¥ 111.50B¥ 112.22B¥ 95.87B¥ 74.18B
Cash Flow
Free Cash Flow¥ -4.03B¥ -11.07B¥ 31.02B¥ -5.55B¥ 5.10B
Operating Cash Flow¥ 5.84B¥ 1.71B¥ 36.90B¥ 6.99B¥ 13.94B
Investing Cash Flow¥ -10.91B¥ -13.04B¥ -6.69B¥ -7.07B¥ -3.78B
Financing Cash Flow¥ -2.26B¥ -5.23B¥ -4.12B¥ -2.07B¥ -1.10B
Currency in JPY

Takara Bio Inc. Earnings and Revenue History

Takara Bio Inc. Debt to Assets

Takara Bio Inc. Cash Flow

Takara Bio Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis